Eyenovia and SGN Nanopharma team up to develop a treatment for chronic DED
The companies announced that they will be working to develop SGN’s micellar nanoparticle platform to be used with Eyenovia’s Optejet dispenser in a news release.
Report cites potential risk factors for severe spaceflight-associated neuro-ocular syndrome
The study helped identify predisposing factors for severe SANS in astronauts.
How to identify treatment failure and initiate medication switches
Long-term vision and ocular surface health are just part of the puzzle.
Nicox announces recruitment of last US patient in Denali Phase 3 trial of NCX 470
Topline results from the trial continue to be expected in H2 2025.
Sinus congestion can lead to vision changes, dry eye syndrome
Increased pressure and inflammation require prompt treatment to avoid complications.
What happened in optometry this week: July 22 - July 26
Catch up on what happened in optometry during the week of July 22-July 26.
Adolescents with myopia have a higher prevalence of anxiety, mood disorders, study finds
A recent study found that adolescents with myopia that were 16 to 20 years old were twice as likely to develop anxiety and mood disorders.
How contact lens prescription brings sustainability into focus
Partnership helps keep oceans clean by collecting plastic waste, reducing pollution.
NOA 2024: Identifying uncommon etiologies of pediatric uveitis
Kefla G. Brown, OD, MS, overviewed her NOA Convention talk on identifying both common and uncommon etiologies of pediatric uveitis.
Eyenovia, Inc. and Senju Pharmaceutical Co., Ltd. sign new collaboration agreement
The collaboration agreement will allow the two companies to find a potential new treatment for chronic dry eye disease.
Supplements slow disease progression during late stage of dry AMD, study suggests
A new analysis by researchers at the National Institutes of Health shows the benefit of taking AREDS2 formula in late AMD.
OGS Executive Director Lois Schoenbrun announces retirement
Schoenbrun will retire from the organization in December after coming out of retirement to serve as the interim executive director for OGS in 2022.
Bausch + Lomb acquires Trukera Medical, ophthalmic medical diagnostic company
According to the company, the tuck-in acquisition will help expand its surgical presence in the United States and contribute to its leading position in dry eye.
Stability is an important quality in toric lenses
The quality of options for patients has improved in recent years.
ASRS 2024: New data for Susvimo shows sustained efficacy in DME, DR
The 2-year Phase III data demonstrates Susvimo’s potential as an alternative to eye injections to treat diabetic macular edema and diabetic retinopathy.
EyeCon 2024: Oluwatosin U. Smith, MD, talks about her love for research and education
From surgeon to mentor: Smith fuels her commitment to improving glaucoma care by training future ophthalmologists.
What happened in optometry this week: July 15 - July 19
Catch up on what happened in optometry during the week of July 15-July 19.
Optometry Giving Sight launches new year-round fundraising initiative
TEAM-OGS gives practices more fundraising opportunities to end preventable blindness and vision impairment globally throughout the year.
Dropless cataract surgery: Revolutionizing postoperative care for enhanced patient outcomes
Removing drops improves adherence and comfort for most patients.
NOA 2024: NOSA reflects on convention's networking and mentorship opportunities for students
Organization corresponding secretary Babirekere Bakama weighs in on her favorite learning opportunities at this year’s NOA Convention.
